Maƙala
Azure B: ƙazantar methylene blue, samfurin metabolism, da sinadarin bincike
Azure B wani sinadari ne da ya bambanta a tsarin sinadarai amma yana da kusanci da methylene blue. Yana iya kasancewa tun farko a cikin samfurin methylene blue, ya bayyana bayan jiki ya sarrafa methylene blue, ko kuma a samar da shi daban don wani gwaji. Waɗannan bayanai ba sa saɓawa juna. Suna bayyana inda sinadarin ya fito da kuma abin da mai bincike yake son sani game da shi.
Wannan bambanci yana da muhimmanci wajen fassara takardar shaidar nazari ko wata da'awa game da aikin halittu. Kiran Azure B samfurin metabolism mai aiki ba yana nufin cewa adadin da ba a sarrafa ba a cikin kwalba abin so ne. Haka kuma, kiran sa ƙazanta ba yana nufin ba ya da aikin halittu.
Me ke canzawa a tsarin sinadarai?
Azure B shi ne samfurin methylene blue da aka cire masa methyl guda ɗaya. An maye gurbin rukuni ɗaya na methyl da ke manne da nitrogen da hydrogen. An bayyana wannan alaƙa a cikin tattaunawar sinadarai da Figure 1 na bita da Schirmer da abokan aikinsa suka yi. Wannan takamaiman canji ne na tsarin sinadari, ba kawai wani suna dabam na methylene blue ba.
Haka kuma ya bambanta da reduction zuwa leucomethylene blue. Reduction yana canza oxidation state; N-demethylation kuwa yana canza substituent na nitrogen. Ɗaukar duka hanyoyin biyu kawai a matsayin “methylene blue yana zama mara launi” yana kawar da bambancin da ake buƙata wajen fassara metabolism. Sunayen dyes masu kama da juna suna buƙatar irin wannan taka-tsantsan: Azure A, Azure B, da methylene blue ba sunaye ne da za a iya musanya su ba. Jagorar sinadarai masu kama da juna a suna ta tattauna wannan matsalar suna.
Asali uku, tambayoyi uku daban-daban
Zanen da ke bangon gaba yana raba hanyoyi uku na bincike. Teburin yana bayyana hujjojin da ake buƙata a kowace hanya.
| Inda Azure B ya shiga binciken | Tambayar da ake yi | Hujja mai amfani | Ƙarshe da ba za a iya fitarwa ba |
|---|---|---|---|
| Ya riga ya kasance a cikin kayan farawa | Me wannan batch ɗin ya ƙunsa? | Hanyar da ke warewa kuma tana auna Azure B, wadda aka danganta da lot ɗin da ƙayyadaddun sharuɗɗan da suka dace | Adadin da aka gano yana inganta tasirin samfurin |
| An gano bayan fallasa ga methylene blue | Waɗanne sinadarai ne suke kasancewa a tsawon lokaci? | Nazarin kayan farawa tare da jerin ma'aunan halittu da aka tabbatar da ingancinsu | Dole ne kowace molecule da aka gano ta samuwa a cikin jiki |
| An ƙara shi a matsayin sinadari da aka tantance daban | Me Azure B da kansa yake yi? | Shaidar asali, tsarki, concentration, comparator, da takamaiman experimental endpoint | Irin wannan tasiri yana faruwa ga marasa lafiya da ke shan methylene blue |
Ana iya sauƙin kau da kai daga layin tsakiya. Idan Azure B yana cikin kayan da aka bayar, samfurin halittu da aka ɗauka daga baya zai iya ƙunsar duka sinadarin da ya riga ya kasance da wanda aka samar sabo. Tabbatar da cewa an samar da shi yana buƙatar fiye da kawai gano peak bayan fallasa.
Azure B a cikin kayan farawa
Wata tsohuwar nazarin analytical ta ba da misali mai amfani na dalilin da ya sa ƙaramin sinadari a cikin cakuda zai iya zama da muhimmanci. Masu binciken da suka nazarci iodination na methylene blue ta amfani da HPLC–mass spectrometry sun gano cewa babban iodinated product ya samo asali ne daga ƙazantar Azure B. Samfuran methylene blue da aka yi nazari a kansu sun ƙunshi kusan 7–8% Azure B. A ƙarƙashin yanayin reaction ɗinsu, iodinated Azure B ya fi iodinated methylene blue yawa sosai.
Waɗannan percentages suna bayyana kayan da aka yi amfani da su a waccan nazarin ta 1999. Ba su tabbatar da acceptable impurity limit na yau ko composition na samfurin wani supplier ba. Gwajin yana nuna takamaiman batu mafi ƙanƙanta: sinadarin da ya fi yawa a kayan farawa ba lallai ne shi ne zai samar da reaction product mafi yawa ba.
Don takardar shaidar nazari, bincika takamaiman sakamakon Azure B, units, hanyar gwaji, reporting limit, da lot identity. Total dye assay da related-substances test suna amsa tambayoyi daban-daban. Sakamakon “undetected” ma yana buƙatar detection ko reporting limit domin a iya fassara shi. Duba yadda ake karanta takardar shaidar nazarin methylene blue don ƙarin binciken da ya shafi takardar gaba ɗaya.
Azure B da ke samuwa yayin metabolism
Nazarin metabolism yana buƙatar analytical separation na parent compound da metabolite ɗinsa. Kim da abokan aikinsa sun ƙirƙiri hanyar LC–MS/MS da ke auna sinadarai biyun a cikin rat plasma. Calibration range ɗinsu ya kasance 1–1,000 ng/mL ga kowane sinadari, tare da lower quantification limit na 1 ng/mL ta amfani da 20 microlitres na rat plasma. Daga nan suka yi amfani da hanyar a cikin rat pharmacokinetic study.
Wannan bayani yana da muhimmanci domin hanyar aunawa tana da takamaiman sample context. Validation a cikin rat plasma ba ya tabbatar kai tsaye da accuracy a cikin human plasma, urine, ko concentrated commercial solution. Hanyar tana nuna yadda masu bincike za su iya bibiyar sinadarai biyu daban-daban; ba ta samar da human dosing rule ba.
Bayanan human exposure ma suna nuna dalilin da ya sa fixed metabolite percentage guda ɗaya bai wadatar ba. Sashen clinical pharmacology na methylene blue injection label ya bayar da rahoton ƙarin Azure B exposure a mahalarta masu renal impairment. Exposure a tsawon lokaci yana nuna formation, distribution, da elimination, ba composition na kwalba kaɗai ba. Route, sampling time, da measured compartment duk suna da muhimmanci wajen kwatanta waɗannan sakamakon.
Abin da gwaje-gwajen kai tsaye suka nuna
Azure B yana da pharmacological activity da za a iya aunawa. Tambayar da ta fi amfani ita ce wane target ne, kuma a ƙarƙashin waɗanne yanayi.
A cikin wata nazarin 2012 da ta yi amfani da recombinant human monoamine oxidase, Azure B ya hana MAO-A da IC50 na 11 nM, idan aka kwatanta da 70 nM na methylene blue a ƙarƙashin yanayi iri ɗaya. IC50 shi ne concentration da ke da alaƙa da 50% inhibition a wannan assay. Azure B ya kuma hana MAO-B, amma a concentration mafi girma sosai: 968 nM. Masu binciken sun bayar da rahoton reversible inhibition.
Waɗannan sakamakon suna goyon bayan yiwuwar gudummawa ga tasirin halittu da interactions, ciki har da tambayoyi game da methylene blue da neurotransmitters. Ba sa nufin cewa Azure B ya fi kyau sau shida a matsayin magani. Ratio ɗin yana bayyana inhibition na enzyme guda ɗaya a cikin kwatancen gwaji guda ɗaya.
Wani gwajin human cholinesterase na daban yana nuna iyakar irin wannan generalization. IC50 values na Azure B sun kasance 0.486 micromolar ga acetylcholinesterase da 1.99 micromolar ga butyrylcholinesterase. Methylene blue ya fi potent a waɗannan assays ɗin, da respective values na 0.214 da 0.389 micromolar. Tsarin fifikon ya juya bisa biological target. Babu ɗaya daga cikin sakamakon da da kansa yake tabbatar da improved cognition ko treatment na Alzheimer's disease.
Daga aikin gwaji zuwa fassarar clinical
Gwaje-gwaje a cikin dabbobi gaba ɗaya suna ƙara wani matakin hujja ba tare da warware clinical efficacy ba. A cikin rat study na Delport da abokan aikinsa, Azure B ya rage immobility a cikin acute forced-swim test, tare da methylene blue da imipramine a cikin comparators. Takardar binciken ta kira wannan antidepressant-like effect. Gwajin behavioral ne a cikin beraye, ba trial da ke auna recovery from depression a cikin marasa lafiya ba.
Ga kowace da'awa game da Azure B, da farko a tantance kayan da aka gwada. Sannan a tantance organism ko assay, exposure, da endpoint. A ƙarshe, a bincika ko ƙarshe yana magana ne kan composition, metabolism, enzyme activity, animal behavior, ko clinical benefit. Waɗannan matakan suna hana a ɗauki sakamakon batch-quality a matsayin treatment claim, kuma suna hana a ɗauki experimental mechanism a matsayin established patient outcome.